Search

Noble E. Jarrell

Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1625, 1699, 1622, 1624, 1609
Total Applications
1419
Issued Applications
950
Pending Applications
180
Abandoned Applications
334

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19003568 [patent_doc_number] => 20240067639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS [patent_app_type] => utility [patent_app_number] => 18/044260 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54883 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044260 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044260
SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS Sep 7, 2021 Pending
Array ( [id] => 18937402 [patent_doc_number] => 20240032541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => HERBICIDAL COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/044821 [patent_app_country] => US [patent_app_date] => 2021-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20835 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044821 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044821
HERBICIDAL COMPOUNDS Sep 5, 2021 Pending
Array ( [id] => 17774942 [patent_doc_number] => 20220241291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => OXYGEN LINKED PYRIMIDINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/465541 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465541 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465541
OXYGEN LINKED PYRIMIDINE DERIVATIVES Sep 1, 2021 Abandoned
Array ( [id] => 20343080 [patent_doc_number] => 12466802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Nebivolol synthesis method and intermediate compound thereof [patent_app_type] => utility [patent_app_number] => 17/465606 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12373 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465606
Nebivolol synthesis method and intermediate compound thereof Sep 1, 2021 Issued
Array ( [id] => 18698601 [patent_doc_number] => 20230329083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => ORGANOMETALLIC COMPLEX, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE [patent_app_type] => utility [patent_app_number] => 18/025112 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025112 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025112
ORGANOMETALLIC COMPLEX, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE Aug 29, 2021 Pending
Array ( [id] => 18512713 [patent_doc_number] => 20230228927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL AND PHOTOCHROMIC LENS [patent_app_type] => utility [patent_app_number] => 18/000956 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000956 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000956
POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL AND PHOTOCHROMIC LENS Aug 29, 2021 Pending
Array ( [id] => 18692481 [patent_doc_number] => 20230322744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => COMPOUNDS AS GLP-1R AGONISTS [patent_app_type] => utility [patent_app_number] => 18/042443 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -73 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042443 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042443
COMPOUNDS AS GLP-1R AGONISTS Aug 19, 2021 Pending
Array ( [id] => 17532458 [patent_doc_number] => 20220111067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/406326 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/406326
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof Aug 18, 2021 Issued
Array ( [id] => 18657615 [patent_doc_number] => 20230303539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/021334 [patent_app_country] => US [patent_app_date] => 2021-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021334 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/021334
IMMUNOREGULATORY COMPOUND AND ANTITUMOR APPLICATION THEREOF Aug 11, 2021 Pending
Array ( [id] => 17520458 [patent_doc_number] => 20220106307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 17/398478 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23527 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398478 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398478
PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES Aug 9, 2021 Pending
Array ( [id] => 18649364 [patent_doc_number] => 20230295162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/019868 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019868 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/019868
SYNTHESIS OF NOVEL IMIPRIDONE DERIVATIVES AND THEIR EVALUATION FOR THEIR ANTICANCER ACTIVITY Aug 4, 2021 Pending
Array ( [id] => 17426942 [patent_doc_number] => 20220054650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => Methylene Carbamate Linkers for use with Targeted-Drug Conjugates [patent_app_type] => utility [patent_app_number] => 17/391580 [patent_app_country] => US [patent_app_date] => 2021-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391580 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/391580
Methylene Carbamate Linkers for use with Targeted-Drug Conjugates Aug 1, 2021 Abandoned
Array ( [id] => 19096486 [patent_doc_number] => 20240115713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => POLYETHYLENE GLYCOL CONJUGATE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/016909 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 914 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016909 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/016909
POLYETHYLENE GLYCOL CONJUGATE DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jul 20, 2021 Pending
Array ( [id] => 18900574 [patent_doc_number] => 20240016059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => ORGANIC ELECTROLUMINESCENT MATERIAL AND METHOD PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 17/426268 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426268 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/426268
ORGANIC ELECTROLUMINESCENT MATERIAL AND METHOD PREPARING THE SAME Jul 19, 2021 Pending
Array ( [id] => 18597208 [patent_doc_number] => 20230272002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => PHOTOREDOX PROTEIN MODIFICATION [patent_app_type] => utility [patent_app_number] => 18/005519 [patent_app_country] => US [patent_app_date] => 2021-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005519 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/005519
PHOTOREDOX PROTEIN MODIFICATION Jul 14, 2021 Pending
Array ( [id] => 19737158 [patent_doc_number] => 12213965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => Riluzole prodrugs and their use [patent_app_type] => utility [patent_app_number] => 17/367484 [patent_app_country] => US [patent_app_date] => 2021-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 40906 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/367484
Riluzole prodrugs and their use Jul 4, 2021 Issued
Array ( [id] => 20129104 [patent_doc_number] => 12371406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Dual acting FKBP12 and FKBP52 inhibitors [patent_app_type] => utility [patent_app_number] => 17/362688 [patent_app_country] => US [patent_app_date] => 2021-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 8864 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362688 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/362688
Dual acting FKBP12 and FKBP52 inhibitors Jun 28, 2021 Issued
Array ( [id] => 17156030 [patent_doc_number] => 20210317081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => (+)-3-(2,3-DIFLUOROPHENYL)-3-METHOXYPYRROLIDINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR PREPARATION THEREOF AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/358494 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11115 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358494 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/358494
(+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine or pharmaceutically acceptable salts thereof, a process for preparation thereof and uses thereof Jun 24, 2021 Issued
Array ( [id] => 17356742 [patent_doc_number] => 20220017538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => THIOESTER PRODRUGS OF MACROCYCLES AS INHIBITORS OF HISTONE DEACETYLASES [patent_app_type] => utility [patent_app_number] => 17/358656 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/358656
THIOESTER PRODRUGS OF MACROCYCLES AS INHIBITORS OF HISTONE DEACETYLASES Jun 24, 2021 Abandoned
Array ( [id] => 18690905 [patent_doc_number] => 20230321067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/000165 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 149316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -76 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000165 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000165
DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES Jun 20, 2021 Abandoned
Menu